Publications

5674 Results

Will transitioning from paper to web-based data collection be successful in an aging male study population?

Authors
M Yee;J Hartline;P Goodman;A Darke;J Crowley
Journal / Conference
American Society of Preventive Oncology, poster;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

A prudent diet attenuates lung function decline in cigarette smokers

Authors
W Tang;KA Guertin;K Arnold;J Crowley;J Hartline;P Goodman;C Tangen;L Minasian;SM Lippman;EA Klein;PA Cassano
Journal / Conference
The FASEB Journal 27:847.17; American Society of Nutrition at Experimental Biology Annual Mtg (April 20-24, 2013, Boston, MA), poster;
Year
2013
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000C

S0221: Comparison of 2 schedules of paclitaxel as adjuvant therapy for breast cancer

Authors
G Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;JK Cho;K Rinn;K Albain;H Chew;GV Burton;TD Moore;G Srkalovic;B McGregor;L Flaherty;RB Livingston;D Lew;J Gralow;G Hortobagyi
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr CRA1008); American Society of Clinical Oncology Annual Meeting, oral presentation;
Year
2013
Research Committee(s)
Breast
Study Number(s)
S0221

SWOG S0919: A phase 2 study of idarubucin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia

Authors
A Advani;S McDonough;E Copelan;C Willman;D Mulford;A List;M Sekeres;M Othus;HP Erba;F Appelbaum
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 7028); American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0919

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Authors
M Neuhouser;EA Platz;C Till;C Tangen;P Goodman;A Kristal;H Parnes;Y Tao;WD Figg;MS Lucia;A Hoque;AW Hsing;IM Thompson;M Pollak
Journal / Conference
Cancer Prevention Research 6(2):91-99;
Year
2013
Research Committee(s)
Cancer Control
PMID
PMID23315596
PMC
PMC3565024
Study Number(s)
SWOG-9217

Chemotherapy outcomes by histological subtypes of non-small cell lung cancer: analysis of the SWOG database for antimicrotubule-platinum therapy

Authors
K Kelly;K Chansky;P Mack;P Lara;FR Hirsch;WA Franklin;A Wozniak;MJ Edelman;SK Williamson;DR Gandara
Journal / Conference
Clinical Lung Cancer 14(6):627-635;
Year
2013
Research Committee(s)
Lung
PMID
PMID23910067
PMC
PMC4122504
Study Number(s)
S0003, SWOG-9308, SWOG-9509, S9806

Value of information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics

Authors
JJ Carlson;R Thariani;J Roth;J Gralow;NL Henry;L Esmail;P Deverka;S Ramsey;L Baker;D Veenstra
Journal / Conference
Medical Decision Making, 33(4):463-471;
Year
2013
Research Committee(s)
Breast
PMID
PMID2365833
PMC
PMC3933300
Study Number(s)
S1007

A randomized, double blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in persons with resected stage I non-small cell lung cancer (ECOG 5597)

Authors
D Karp;S Lee;S Keller;G Shaw Wright;S Aisner;S Belinsky;D Johnson;M Johnston;G Goodman;G Clamon;G Okawara;R Marks;E Frechette;W McCaskill-Stevens;SM Lippman;J Ruckdeschel;F Khuri
Journal / Conference
Journal of Clinical Oncology 31(33):4179-4187;
Year
2013
Research Committee(s)
Lung
PMID
PMID24002495
PMC
PMC3821010
Study Number(s)
E5597

Relevance of platinum (plat) sensitivity status in previously treated extensive stage small cell lung cancer (ES-SCLC) in the modern era: a patient level analysis of SWOG trials

Authors
P Lara, Jr;J Moon;M Redman;K Kelly;J Allen;B Gitlitz;PC Mack;D Gandara
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr 7511); ASCO Annual Meeting (May 31-June 4, 2013, Chicago, IL), poster discussion;
Year
2013
Research Committee(s)
Lung
Study Number(s)
S0327, S0435, S0802

A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu-negative breast cancer: SWOG-NSABP S1207

Authors
M Chavez-Macgregor;W Barlow;AM Gonzalez-Angulo;P Rastogi;E Mamounas;P Ganz;AF Schott;S Paik;D Lew;H Bandos;G Hortobagyi
Journal / Conference
Journal of Clinical Oncology 31(suppl; abstr TPS657); 2013. American Society of Clinical Oncology Annual Meeting (May 31-June 4, 2013, Chicago, IL), TIPS general poster session;
Year
2013
Research Committee(s)
Breast
PMID
https://meetinglibrary.asco.org/record/86424/abstract
Study Number(s)
S1207